Event Type: The disclosure intimates scheduled one-on-one meetings with Analysts/Institutional Investors.
Date and Time: The meetings are scheduled for Friday, November 20, 2026. The specific scheduled times are:
Mirae Mutual Fund: 09.45 AM – 10.45 AM IST
UTI Mutual Fund: 11.15 AM – 12.15 PM IST
Tata Mutual Fund: 12.45 PM – 01.45 PM IST
Mode and Location: All meetings are scheduled to be held in-person in Mumbai.
Stated Purpose: The purpose of the meetings is for interaction with analysts and institutional investors.
Management Participants: The document does not specify any management participants or their designations.
Presentation Availability: A presentation for the meeting is available at the provided URL: https://d28c6jni2fmamz.cloudfront.net/ECPH1Q2FY27_f8e43c260a.pdf. The disclosure will also be made available on the Company's website at www.starhealth.in.
UPSI Statement: The document contains standard compliance language, indicating it is a disclosure made under Regulation 30 of the SEBI (LODR) Regulations, 2015, but it does not include an explicit statement confirming that no Unpublished Price Sensitive Information (UPSI) will be shared.
Additional Notes Section
Financial Data: No financial data, results, guidance, or strategic updates were disclosed in this announcement. The provided presentation link suggests discussion may pertain to Q2 FY27, but this is not confirmed in the text of the letter.
Attachments: The document itself is the primary intimation letter. It references an external presentation deck but does not list it as a formal attachment to the filing.
Logistics: The note clarifies that the meeting schedule is subject to changes due to exigencies on the part of the analysts/investors.